ID Biomedical to seek U.S. accelerated approval process for influenza vaccine

VANCOUVER (CP) - ID Biomedical Corp. said Tuesday that the U.S. Food and Drug Administration is allowing it to seek accelerated approval of its influenza vaccine....More